The independent source for health policy research, polling, and news.
Showing 1 - 19 of 19
A national survey finds that medical schools should do more to help doctors with disabilities thrive. Although some schools do make needed accommodations, others need to take basic steps to help.
Philadelphia officials gave the OK to establishing safe-injection sites for drug users. But it's unclear where the sites would be located and who would fund and operate them.
In a low-tech snafu, information about HIV treatment was visible through the cellophane window on envelopes sent to about 12,000 consumers.
Treatment for opioid addiction can be expensive and difficult to coordinate. That might make some people tempted to think they can overcome the addiction on their own. This rarely works.
Before the federal health law guarantee that consumers cannot be turned down because of their medical history, it was difficult to balance insurers’ needs to make a profit and individuals’ needs for coverage.
Matching with a residency program had an added layer of stress this year for doctors-in-training from the countries affected by President Donald Trump's travel ban.
Dentistry is at a crossroads and many in the field are reassessing their narcotics prescribing habits.
Hepatitis C can be passed from mothers to babies, but it often is not diagnosed until much later in a person's life. Specialists are debating new screening practices to catch the disease earlier.
A tough diagnosis and a high-deductible insurance plan motivated one couple to shop carefully for care. But they hit a snag -- inaccurate prices on online calculators. Who can comparison shop if the price tags are wrong?
Consumers in New York are getting new protections against “balance billing,” where insurers bill patients for the difference between what insurers pay and what providers want, and states considering similar laws are watching closely.
A soon-to-be-announced Supreme Court ruling could threaten health insurance subsidies for millions of people in about three dozen states. But many state officials aren't sharing contingency plans lest they be seen as supporting Obamacare.
Under a new process set out by the health law, the FDA approved the first so-called biosimilar drug for sale in the U.S. It’s a copy of the cancer medicine Neupogen that will be sold under the brand name Zarxio.
Fear keeps many patients and doctors from talking to each other about end-of-life care. One company, hired by insurers, has made a rather unusual business fostering those conversations.
Rhodes acknowledges the study did not examine the quality of care received, the accessibility for returning patients or the role of cost in determining patients’ real access to services.
A new study shows that younger people in eight cities who make more than about $32,000 a year won't get tax credits to help pay for insurance premiums.
In Philadelphia and across the country, librarians are digging into the details of the Affordable Care Act to help patrons sign up for health insurance.
Only about half the states so far are planning to expand Medicaid coverage to thousands of low-income adults. Pennsylvania's Republican governor has a plan to do that, with caveats.
The pools are intended to help people until Jan. 1, 2014, when the federal health law's provision banning insurers from denying coverage to people with pre-existing conditions or charging them more takes effect.
Stay informed by signing up for the Morning Briefing and other emails:
© 2026 KFF